Detailed Narrative
Q1 FY26 Performance Highlights
Laxmi Dental achieved its highest-ever quarterly revenue of ₹66 crores in Q1 FY26, marking a 10% year-on-year and 8% sequential growth. The company reported a healthy EBITDA of ₹11.9 crores, translating to an 18.2% margin, and a PAT of ₹8.3 crores with a 13% margin. Gross profit stood at ₹48.1 crores, maintaining a 73.3% margin. Finance costs significantly reduced to ₹0.5 crores from ₹1.4 crores, following the full repayment of debt.
Strategic Investment in AI Dentistry
The company made a strategic investment in IDBG AI Dent Global Private Limited, a startup focused on AI-powered dental imaging and X-ray analysis software. This acquisition is a key step towards increasing the penetration of digital dentistry and enhancing treatment quality and patient experience. The AI product is expected to launch within the current financial year and contribute to future revenue growth.
Product Mix and Digitalization Drive
The product mix saw the Dental Laboratory business grow by 8%, contributing 59% of revenues, while Aligner Solutions revenue rose by 18%, accounting for 28% of revenues. Scanner sales grew robustly by 26% YoY, with over 200 scanners sold in Q1 FY26. Management emphasized digitalization, particularly through scanners, as a critical enabler for operational efficiency and long-term profitability, despite scanners having lower gross margins than other products.
Growth Outlook and Geographical Diversification
Laxmi Dental maintains its full-year FY26 revenue growth guidance of 20-25%, anticipating sequential growth of 8-10% quarter-on-quarter. The Kids-e-Dental business is also projected to grow by 20-25% upon receiving pending regulatory approvals in Q3 or Q4 FY26. The company is actively diversifying its business geographically, with strong efforts in APAC, the Middle East, and Europe, to mitigate risks like the new 25% US tariffs.
Capital Allocation and Debt Repayment
In line with its IPO objectives, Laxmi Dental fully repaid its debt during the quarter, leading to a significant reduction in finance costs. The company plans for capital expenditure in the range of ₹68 crores over the next two years, utilizing IPO funds for expansion, particularly in digital dentistry and brand building. This capex is deemed sufficient for planned growth and capacity enhancements.